Dr. Reddy's Drops Patent Challenge To Glaxo's Zofran

Law360, New York (April 29, 2004, 12:00 AM EDT) -- Indian generic drug maker Dr. Reddy's Laboratories has withdrawn its challenge to the main U.S. patent on GlaxoSmithKline anti-nausea drug Zofran, the U.K. drug maker said on Thursday.

As a result, Dr. Reddy's will not attempt to launch a cheap generic version of the product in the U.S. until after the compound patent expires in July 2005.

Glaxo also has two "method-of-use" patents expiring in 2005 and 2006.

GlaxoSmithKline had filed a lawsuit against Dr Reddy's Laboratories Ltd in the U.S.District Court for the district of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.